Sort
25,944 grants matching “neurodegeneration”
Degenerative and Dementing Diseases of Aging
$1,625,072Stanley B Prusiner · University Of California, San Francisco · P01 · FY2012 · AG
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,623,635Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2020 · AG
MECHANISMS UNDERLYING MICROGLIA DYSFUNCTION DURING NEURODEGENERATION
$1,622,124Elizabeta Gjoneska · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES
Preclinical Development of JNK3 Inhibitors to Treat Parkinson's Disease
$1,620,133Philip Lograsso · Scripps Research Institute, The · U01 · FY2011 · NS
Preclinial Development of JNK3 Inhibitors to Treat Parkinson's Disease
$1,620,133Philip Lograsso · Scripps Research Institute, The · U01 · FY2011 · NS
Childhood Neurodegenerative Lysosomal Storage Disorders
$1,617,990Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD
Childhood Neurodegenerative Lysosomal Storage Disorders
$1,617,704Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Roles of Cdk5 in neurodevelopment and neurodegeneration
$1,617,120Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
BOTANICAL CENTER FOR AGE-RELATED DISEASES
$1,616,634Purdue University West Lafayette · P50 · FY2003 · AT
A Systems Approach to Targeting Innate Immunity in AD
$1,613,148Todd E. Golde · University Of Florida · U01 · FY2018 · AG
Functional analysis of glia in tauopathy
$1,613,138Mel B Feany · Brigham And Women'S Hospital · RF1 · FY2025 · AG
Regulation Of Intracellular Iron Metabolism
$1,612,762Tracey A. Rouault · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
MECHANISMS UNDERLYING MICROGLIA DYSFUNCTION DURING NEURODEGENERATION
$1,611,954Elizabeta Gjoneska · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
Illuminating neurodegenerative tauopathy from somatic genomic landscapes of single human brain cells
$1,611,000Michael B Miller · Brigham And Women'S Hospital · DP2 · FY2023 · AG
Disrupted Lipid Metabolism in Alzheimer's Disease
$1,610,885Fei Yin · University Of Arizona · RF1 · FY2024 · AG
Design And Development Of Experimental Therapeutics
$1,610,701Nigel H. Greig · National Institute On Aging · ZIA · FY2011 · AG
NOVEL EXPOSOMICS AND EXTRACELLULAR VESICLE BIOMARKERS TO UNRAVEL GENE - ENVIRONMENT INTERACTIONS AND MECHANISMS OF NEURODEGENERATION IN PARKINSON'S DISEASE
$1,610,694The Trustees Of Columbia University In The City Of New York · · FY2022 · Defense Health Agency
Discovery of Drugs that Modulate Neuroinflammation for the treatment of Alzheimer's Disease
$1,609,985Kevin Hodgetts · Brigham And Women'S Hospital · U01 · FY2022 · AG
The Physical Biology of Neurodegeneration in Sporadic Amyotrophic Lateral Sclerosis/Frontotemporal Dementia
$1,609,485Hemali Phatnani · Columbia University Health Sciences · R01 · FY2023 · NS
Mechanisms Of Action Of Psychoactive Drugs
$1,609,403De-Maw Chuang · National Institute Of Mental Health · ZIA · FY2011 · MH
Sodium pump ligands in blood pressure regulation and profibrotic signaling in hypertension, chronic kidney disease and aging in males and females
$1,606,197Olga V Fedorova · National Institute On Aging · ZIA · FY2025 · AG
Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models
$1,603,971Joshua M Shulman · Baylor College Of Medicine · U01 · FY2022 · AG
Preclinial Development of JNK3 Inhibitors to Treat Parkinson's Disease
$1,603,454Philip Lograsso · Scripps Research Institute, The · U01 · FY2009 · NS
Preclinical Development of JNK3 Inhibitors to Treat Parkinson's Disease
$1,603,454Philip Lograsso · Scripps Research Institute, The · U01 · FY2009 · NS
Investigating the Functional Impact of AD Risk Genes on Neuro-Vascular Interactions
$1,603,401Sally Temple · Regenerative Research Foundation · U01 · FY2023 · AG